| ²é¿´: 2317 | »Ø¸´: 13 | |||
hl1013ͳæ (³õÈëÎÄ̳)
|
[½»Á÷]
¡¾½»Á÷¡¿¼×»ÇËáÒÁÂíÌæÄáÔÁÏÒ©ÔÓÖÊÎÊÌâ
|
| Sample TextÈ«ºÏ³ÉµÄ¼×»ÇËáÒÁÂíÌæÄáÔÁÏÒ©£¬ÓÐÒ»¸öÔÓÖʺ¬Á¿0.16%£¬×ÜÔÓÖÊ0.44%£¬ÓÐ×ö¸öÒÁÂíÌæÄáµÄ´óϺÃÇÄܸøÎÒÖ¸µãÏ£¬¿ÉÄÜÊÇʲô¶«Î÷ÄØ£¿¼±Çó£¡ |
» ²ÂÄãϲ»¶
288Çóµ÷¼Á
ÒѾÓÐ14È˻ظ´
Ò»Ö¾Ô¸ÏôóÉúÎïѧ332Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
085600£¬321·ÖÇóµ÷¼Á
ÒѾÓÐ17È˻ظ´
һ־Ը³¶«´óѧ071000ÉúÎïѧѧ˶³õÊÔ·ÖÊý276Çóµ÷¼Á
ÒѾÓÐ16È˻ظ´
²ÄÁÏ»¯¹¤×Ü·Ö334Çóµ÷¼Á
ÒѾÓÐ11È˻ظ´
288Çóµ÷¼Á£¬Ò»Ö¾Ô¸»ªÄÏÀí¹¤´óѧ071005
ÒѾÓÐ13È˻ظ´
¸´ÊÔµ÷¼Á£¬Ò»Ö¾Ô¸Ö£ÖÝ´óѧ²ÄÁÏÓ뻯¹¤289·Ö
ÒѾÓÐ20È˻ظ´
Ò»Ö¾Ô¸Öпƴó070300»¯Ñ§£¬314·ÖÇóµ÷¼Á
ÒѾÓÐ4È˻ظ´
285Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ7È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÔÁÏÒ©ÔÓÖʽ϶àÔõô°ì
ÒѾÓÐ18È˻ظ´
¡¾Ô´´¡¿×ªÈö÷Ìæ¿¨Î¤¡¢ÄªÎ÷ɳÐÇ¡¢ÒÁÂíÌæÄáµÈ¶àÖÖÔÁÏÒ©¹¤ÒÕ£¨º¬¸÷ÖÖ±ê×¼£©£¬·Ç³ÏÎðÈÅ
ÒѾÓÐ6È˻ظ´
¡¾Ô´´¡¿´ïÉ³ÌæÄáÏîĿתÈÃ
ÒѾÓÐ21È˻ظ´
¡¾ÇóÖú¡¿ÔÁÏÒ©ËáÆÆ»µºÍ¼îÆÆ»µÊµÑéµÄÁ½¸ö¸öÎÊÌâ
ÒѾÓÐ32È˻ظ´
¡¾ÇóÖú¡¿¹ØÓÚÉú²úµÄÔÁÏÒ©µÄȱ·¦ÎÊÌâ
ÒѾÓÐ7È˻ظ´
¡¾ÌÖÂÛ¡¿¼×»ÇËáÒÁÂíÌæÄáµÄ¸±×÷ÓÃ
ÒѾÓÐ14È˻ظ´
¡¾ÇóÖú¡¿¼×»ÇËáÒÁÂíÌæÄá ÖÊÁ¿±ê×¼
ÒѾÓÐ20È˻ظ´
¡¾ÌÖÂÛ¡¿¹ØÓÚÔÁÏÒ©ºÏ³ÉµÄÎÊÌâ
ÒѾÓÐ13È˻ظ´
¼×»ÇËáÒÁÂíÌæÄáÖм׻ÇËáÈçºÎ¼ø±ð
ÒѾÓÐ2È˻ظ´
drugmen
½ð³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1392.6
- Ìû×Ó: 934
- ÔÚÏß: 34.6Сʱ
- ³æºÅ: 226651
- ×¢²á: 2006-03-23
- ÐÔ±ð: GG
- רҵ: ·ÖÎö»¯Ñ§

2Â¥2010-11-09 12:31:54
hl1013
ͳæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 240.4
- É¢½ð: 4
- Ìû×Ó: 23
- ÔÚÏß: 84.5Сʱ
- ³æºÅ: 897093
- ×¢²á: 2009-11-08
- ÐÔ±ð: GG
- רҵ: ºÏ³ÉÒ©Îﻯѧ
3Â¥2010-11-13 21:47:06
·¹·¹Í°Í°
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 14 (СѧÉú)
- ½ð±Ò: 3938.6
- ºì»¨: 1
- Ìû×Ó: 454
- ÔÚÏß: 119.9Сʱ
- ³æºÅ: 981594
- ×¢²á: 2010-03-25
- ÐÔ±ð: GG
- רҵ: ÓлúºÏ³É
4Â¥2010-11-16 12:50:14
rokeson
ͳæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 187.6
- ºì»¨: 1
- Ìû×Ó: 32
- ÔÚÏß: 17.1Сʱ
- ³æºÅ: 873899
- ×¢²á: 2009-10-16
- ÐÔ±ð: GG

5Â¥2010-11-23 21:35:12
reallove2935
½ûÑÔ (ÖøÃûдÊÖ)
¡ï
qinhy(½ð±Ò+1):¶àлָ½Ì£¬»¶Ó³£À´Ò©Ñ§°æ£¡ 2010-11-29 10:18:51
qinhy(½ð±Ò+1):¶àлָ½Ì£¬»¶Ó³£À´Ò©Ñ§°æ£¡ 2010-11-29 10:18:51
|
±¾ÌûÄÚÈݱ»ÆÁ±Î |
6Â¥2010-11-24 08:29:43
paulixu
Ìú¸Ëľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 32 (СѧÉú)
- ½ð±Ò: 6431.5
- É¢½ð: 120
- ºì»¨: 8
- Ìû×Ó: 757
- ÔÚÏß: 336Сʱ
- ³æºÅ: 448203
- ×¢²á: 2007-11-01
- ÐÔ±ð: GG
- רҵ: ºÏ³ÉÒ©Îﻯѧ
¡ï
qinhy(½ð±Ò+1):¹¤ÒÕ·Ïߣ¬Ã²ËƲ»Ì«·½±ã°É 2010-11-29 10:19:14
qinhy(½ð±Ò+1):¹¤ÒÕ·Ïߣ¬Ã²ËƲ»Ì«·½±ã°É 2010-11-29 10:19:14
| ¿ÉÒÔ¸ø³ö¹¤ÒÕ·ÏßÂ𣬰ïÄã²Â²Â£¡ |
7Â¥2010-11-28 19:09:36
harder
ľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 8456.8
- É¢½ð: 48
- Ìû×Ó: 1445
- ÔÚÏß: 419.5Сʱ
- ³æºÅ: 253439
- ×¢²á: 2006-05-21
- ÐÔ±ð: GG
- רҵ: Ò©Îﻯѧ

8Â¥2011-01-04 13:19:43
¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
|
tert-butyl 4-(4-(4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenylcarbamoyl)benzyl)piperazine-1-carboxylat N-(4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide 4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide |
9Â¥2011-08-18 11:42:21
sduhhzice
Ìú¸Ëľ³æ (СÓÐÃûÆø)
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 5493
- ºì»¨: 3
- Ìû×Ó: 284
- ÔÚÏß: 170.1Сʱ
- ³æºÅ: 1149988
- ×¢²á: 2010-11-18
- ÐÔ±ð: GG
- רҵ: Ò©Àíѧ
10Â¥2011-09-02 15:45:29













»Ø¸´´ËÂ¥